1 views
This Expensive Chip Stock Is Up 140%, Analysts Say It’s Still a Buy
This Expensive Chip Stock Is Up 140%, Analysts Say It’s Still a Buy
No article text in this feed item.
Open the publisher link below for the full story.
More in Markets
Same desk, different stories
MarketsHP Stock Is Historically Cheap, but Can AI Change the Story?
HP Stock Is Historically Cheap, but Can AI Change the Story?
- Markets
Crude Oil Prices Tumble on Hopes for an End to the War in the Middle East
May WTI crude oil (CLK26 ) today is down -1.62 (-1.60%), and May RBOB gasoline (RBK26 ) is down -0.0787 (-2.46%). Crude oil and gasoline prices are sharply lower today amid mounting optimism that the war in the Middle…
- Markets
Does SpaceX's 1-Million-Satellite Vision Offer Bold Upside or Regulatory and Environmental Risk for Investors?
Key PointsSpaceX will likely soon become the biggest IPO in history.
- Markets
Stocks Climb on War-End Optimism
The S P 500 Index ($SPX ) (SPY ) today is up +0.97%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.45%. June E-mini S P futures (ESM26 ) are up +0.96%,…
- Markets
Here's Why Chevron Stock Dipped Lower Today
Key PointsChevron shares dropped as oil prices fell below $100.
- Markets
Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In England
(RTTNews) - Novo Nordisk [NVO] announced on Wednesday, that it has received a significant boost after the National Institute for Health and Care Excellence recommended broader use of Wegovy to help prevent heart…